サマリー

関節リウマチは、主に関節に影響を及ぼす長期的な自己免疫疾患です。
市場の分析と洞察関節リウマチ治療薬の世界市場
関節リウマチ治療の世界市場規模は、2021年の7億2590万米ドルから2028年には9億2300万米ドルに達すると予測され、2022年から2028年の間にCAGR3.1％で推移するとされています。
関節リウマチ治療市場は、人々の間で関節リウマチの発生率が高いことから、予測期間中に成長することが期待されています。

業界標準の分析精度と高いデータ整合性により、本レポートは世界の関節リウマチ治療市場で利用可能な主要機会を明らかにし、プレイヤーが市場での強力な地位を獲得するのに役立つ素晴らしい試みを行っています。本レポートの購入者は、世界の関節リウマチ治療市場の全体規模（売上高）を含む、検証済みで信頼性の高い市場予測にアクセスすることができます。

全体として、本レポートは、プレイヤーが競合他社に対する競争力を獲得し、世界の関節リウマチ治療市場における持続的な成功を確保するために使用できる効果的なツールであることが証明されています。本レポートで提供されるすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証され、再確認されています。本レポートを執筆したアナリストは、世界の関節リウマチ治療市場を詳細に調査するため、独自の業界最高水準の調査・分析アプローチを採用しています。

世界の関節リウマチ治療の範囲と市場規模
関節リウマチ治療薬市場は、プレイヤー別、地域（国）別、タイプ別、用途別に分類されています。世界の関節リウマチ治療市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の収益と予測に焦点を当てます。

タイプ別セグメント
症候性治療薬
中間コルチコステロイド治療薬
疾患修飾性抗リウマチ薬治療薬

用途別セグメント
病院薬局
小売薬局
ドラッグストア

会社別
サノフィ
ファイザー
ロシュ
ジョンソン・エンド・ジョンソン
アッヴィ
イーライリリー
アムジェン
ソビ
ブリストル・マイヤーズ スクイブ

地域別
北米
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
北欧諸国
その他の欧州
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア
中南米
メキシコ
ブラジル
ラテンアメリカの残りの部分
中近東・アフリカ
トルコ
サウジアラビア
UAE
MEAの残りの地域

ページTOPに戻る

目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rheumatoid Arthritis Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Symptomatic Treatment
1.2.3 Intermediate Corticosteroid Therapies
1.2.4 Disease Modifying Antirheumatic Drug Therapies
1.3 Market by Application
1.3.1 Global Rheumatoid Arthritis Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Drug Stores
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Rheumatoid Arthritis Treatment Market Perspective (2017-2028)
2.2 Rheumatoid Arthritis Treatment Growth Trends by Region
2.2.1 Rheumatoid Arthritis Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Rheumatoid Arthritis Treatment Historic Market Size by Region (2017-2022)
2.2.3 Rheumatoid Arthritis Treatment Forecasted Market Size by Region (2023-2028)
2.3 Rheumatoid Arthritis Treatment Market Dynamics
2.3.1 Rheumatoid Arthritis Treatment Industry Trends
2.3.2 Rheumatoid Arthritis Treatment Market Drivers
2.3.3 Rheumatoid Arthritis Treatment Market Challenges
2.3.4 Rheumatoid Arthritis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rheumatoid Arthritis Treatment Players by Revenue
3.1.1 Global Top Rheumatoid Arthritis Treatment Players by Revenue (2017-2022)
3.1.2 Global Rheumatoid Arthritis Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Rheumatoid Arthritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rheumatoid Arthritis Treatment Revenue
3.4 Global Rheumatoid Arthritis Treatment Market Concentration Ratio
3.4.1 Global Rheumatoid Arthritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rheumatoid Arthritis Treatment Revenue in 2021
3.5 Rheumatoid Arthritis Treatment Key Players Head office and Area Served
3.6 Key Players Rheumatoid Arthritis Treatment Product Solution and Service
3.7 Date of Enter into Rheumatoid Arthritis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rheumatoid Arthritis Treatment Breakdown Data by Type
4.1 Global Rheumatoid Arthritis Treatment Historic Market Size by Type (2017-2022)
4.2 Global Rheumatoid Arthritis Treatment Forecasted Market Size by Type (2023-2028)
5 Rheumatoid Arthritis Treatment Breakdown Data by Application
5.1 Global Rheumatoid Arthritis Treatment Historic Market Size by Application (2017-2022)
5.2 Global Rheumatoid Arthritis Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Rheumatoid Arthritis Treatment Market Size (2017-2028)
6.2 North America Rheumatoid Arthritis Treatment Market Size by Type
6.2.1 North America Rheumatoid Arthritis Treatment Market Size by Type (2017-2022)
6.2.2 North America Rheumatoid Arthritis Treatment Market Size by Type (2023-2028)
6.2.3 North America Rheumatoid Arthritis Treatment Market Share by Type (2017-2028)
6.3 North America Rheumatoid Arthritis Treatment Market Size by Application
6.3.1 North America Rheumatoid Arthritis Treatment Market Size by Application (2017-2022)
6.3.2 North America Rheumatoid Arthritis Treatment Market Size by Application (2023-2028)
6.3.3 North America Rheumatoid Arthritis Treatment Market Share by Application (2017-2028)
6.4 North America Rheumatoid Arthritis Treatment Market Size by Country
6.4.1 North America Rheumatoid Arthritis Treatment Market Size by Country (2017-2022)
6.4.2 North America Rheumatoid Arthritis Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Rheumatoid Arthritis Treatment Market Size (2017-2028)
7.2 Europe Rheumatoid Arthritis Treatment Market Size by Type
7.2.1 Europe Rheumatoid Arthritis Treatment Market Size by Type (2017-2022)
7.2.2 Europe Rheumatoid Arthritis Treatment Market Size by Type (2023-2028)
7.2.3 Europe Rheumatoid Arthritis Treatment Market Share by Type (2017-2028)
7.3 Europe Rheumatoid Arthritis Treatment Market Size by Application
7.3.1 Europe Rheumatoid Arthritis Treatment Market Size by Application (2017-2022)
7.3.2 Europe Rheumatoid Arthritis Treatment Market Size by Application (2023-2028)
7.3.3 Europe Rheumatoid Arthritis Treatment Market Share by Application (2017-2028)
7.4 Europe Rheumatoid Arthritis Treatment Market Size by Country
7.4.1 Europe Rheumatoid Arthritis Treatment Market Size by Country (2017-2022)
7.4.2 Europe Rheumatoid Arthritis Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rheumatoid Arthritis Treatment Market Size (2017-2028)
8.2 Asia-Pacific Rheumatoid Arthritis Treatment Market Size by Type
8.2.1 Asia-Pacific Rheumatoid Arthritis Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Rheumatoid Arthritis Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Rheumatoid Arthritis Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Rheumatoid Arthritis Treatment Market Size by Application
8.3.1 Asia-Pacific Rheumatoid Arthritis Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Rheumatoid Arthritis Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Rheumatoid Arthritis Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Rheumatoid Arthritis Treatment Market Size by Region
8.4.1 Asia-Pacific Rheumatoid Arthritis Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Rheumatoid Arthritis Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Rheumatoid Arthritis Treatment Market Size (2017-2028)
9.2 Latin America Rheumatoid Arthritis Treatment Market Size by Type
9.2.1 Latin America Rheumatoid Arthritis Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Rheumatoid Arthritis Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Rheumatoid Arthritis Treatment Market Share by Type (2017-2028)
9.3 Latin America Rheumatoid Arthritis Treatment Market Size by Application
9.3.1 Latin America Rheumatoid Arthritis Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Rheumatoid Arthritis Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Rheumatoid Arthritis Treatment Market Share by Application (2017-2028)
9.4 Latin America Rheumatoid Arthritis Treatment Market Size by Country
9.4.1 Latin America Rheumatoid Arthritis Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Rheumatoid Arthritis Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rheumatoid Arthritis Treatment Market Size (2017-2028)
10.2 Middle East & Africa Rheumatoid Arthritis Treatment Market Size by Type
10.2.1 Middle East & Africa Rheumatoid Arthritis Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Rheumatoid Arthritis Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Rheumatoid Arthritis Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Rheumatoid Arthritis Treatment Market Size by Application
10.3.1 Middle East & Africa Rheumatoid Arthritis Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Rheumatoid Arthritis Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Rheumatoid Arthritis Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Rheumatoid Arthritis Treatment Market Size by Country
10.4.1 Middle East & Africa Rheumatoid Arthritis Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Rheumatoid Arthritis Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Rheumatoid Arthritis Treatment Introduction
11.1.4 Sanofi Revenue in Rheumatoid Arthritis Treatment Business (2017-2022)
11.1.5 Sanofi Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Rheumatoid Arthritis Treatment Introduction
11.2.4 Pfizer Revenue in Rheumatoid Arthritis Treatment Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Rheumatoid Arthritis Treatment Introduction
11.3.4 Roche Revenue in Rheumatoid Arthritis Treatment Business (2017-2022)
11.3.5 Roche Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Rheumatoid Arthritis Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Rheumatoid Arthritis Treatment Business (2017-2022)
11.4.5 Johnson & Johnson Recent Developments
11.5 AbbVie
11.5.1 AbbVie Company Details
11.5.2 AbbVie Business Overview
11.5.3 AbbVie Rheumatoid Arthritis Treatment Introduction
11.5.4 AbbVie Revenue in Rheumatoid Arthritis Treatment Business (2017-2022)
11.5.5 AbbVie Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Rheumatoid Arthritis Treatment Introduction
11.6.4 Eli Lilly Revenue in Rheumatoid Arthritis Treatment Business (2017-2022)
11.6.5 Eli Lilly Recent Developments
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Rheumatoid Arthritis Treatment Introduction
11.7.4 Amgen Revenue in Rheumatoid Arthritis Treatment Business (2017-2022)
11.7.5 Amgen Recent Developments
11.8 Sobi
11.8.1 Sobi Company Details
11.8.2 Sobi Business Overview
11.8.3 Sobi Rheumatoid Arthritis Treatment Introduction
11.8.4 Sobi Revenue in Rheumatoid Arthritis Treatment Business (2017-2022)
11.8.5 Sobi Recent Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Rheumatoid Arthritis Treatment Introduction
11.9.4 Bristol-Myers Squibb Revenue in Rheumatoid Arthritis Treatment Business (2017-2022)
11.9.5 Bristol-Myers Squibb Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer